RGL Research • August 20, 2017
Believe it or not, about 20 years' worth of potentially life-saving drugs are sitting in labs right now, untested. Why? Because they can't get the funding to go to trials; In other words, the financial risk is too high. Roger Stein is a finance guy, and he thinks deeply about mitigating risk. Indeed, he and some colleagues at MIT came up with a promising new financial model that could move hundreds of drugs into the testing pipeline.
Source : https://www.ted.com/talks/francis_collins_we_need_better_drugs_now